deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT04985682

A Study of ADVATE in People With Hemophilia A in India

Phase 4, Multicenter, Prospective, Interventional, Post-Marketing Study in Hemophilia A Patients in India Receiving ADVATE as On-Demand or Prophylaxis Under Standard Clinical Practice

Sponsor: Baxalta now part of Shire

Conditions Hemophilia A
Interventions ADVATE
Updated 9 times since 2021 Last updated: Aug 7, 2023 Started: Jan 14, 2022 Primary completion: Feb 10, 2023 Completion: Feb 10, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hemophilia A and is currently completed. Baxalta now part of Shire leads this study, which shows 9 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Feb 2022 · 2 months · monthly snapshot~Feb 2022 – ~Apr 2023 · 14 months · monthly snapshotRecruiting~Apr 2023 – ~Aug 2023 · 4 months · monthly snapshot~Aug 2023 – ~Apr 2024 · 8 months · monthly snapshotCompleted~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Apr 2024 — Jul 2024 [monthly]

    Completed PHASE4

  5. Aug 2023 — Apr 2024 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

▶ Show 4 earlier versions

  1. Apr 2023 — Aug 2023 [monthly]

    Recruiting PHASE4

  2. Feb 2022 — Apr 2023 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  3. Dec 2021 — Feb 2022 [monthly]

    Not Yet Recruiting PHASE4

  4. Sep 2021 — Dec 2021 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baxalta now part of Shire
  • Takeda Development Center Americas, Inc.
Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations